-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
19 (Xinhua) -- California-based Isis Pharmaceuticals Inc. announced Friday that it will change its name to Ionis Pharmaceuticals Inc. in an apparent attempt to draw a line under the extremist group Islamic State. Lynne Parshall, chief operating officer of
, said: "We decided to change the name of the company in the hope that when people saw or heard our names, we thought of life-saving drugs that we were developing. "
isis pharmaceutical company mainly produces drugs for cancer, heart disease and neurological diseases. When the Islamic State first emerged last year, ISIS said it would not change its name. But in the wake of the Paris attacks, the company's share price plunged about 4 per cent on November 17th for no reason.
company's shares will begin trading on NASDAQ under the "IONS" code on Tuesday (December 22). (Hexun.com)